June 6-11, 2010 - Nuevo Vallarta, Mexico

Editors:   John G. Auniņš,Merck, USA
  Barry C. Buckland, BiologicB, USA
  Kathrin U. Jansen, Pfizer, USA
  Paula Marques Alves, IBET, Portugal

The articles for these proceedings are not peer-reviewed.

Follow

PDF

Final Conference Program, Barry Buckland, John Aunins, Paula Marques Alves, and Kathrin Jansen (Article)

PDF

POTENT, RAPID AND COST-EFFECTIVE INFLUENZA VACCINES MADE IN E. COLI, Thomas Hofstaetter (Article)

PDF

ISCOMATRIX™ ADJUVANT LINKS INNATE AND ADAPTIVE IMMUNE RESPONSES, Debbie Drane (Article)

PDF

INFLUENCE OF HOST CELL DEFENCE DURING INFLUENZA VACCINE PRODUCTION IN MDCK CELLS, Timo Frensing, Claudius Seitz, Bjoern HeynischOtto-von-Guericke, and Udo Reichl (Article)

PDF

DEVELOPMENT OF RECOMBINANT PROTEIN BASED CHEMICAL CONJUGATE MALARIA VACCINES TARGETING THE PRE-ERYTHROCYTIC STAGE, TRANSMISSION BLOCKING, OR BOTH, David L. Narum, Nicholas MacDonald, David Jones, Ruth Ellis, Yimin Wu, and Patrick E. Duffy (Article)

PDF

DEVELOPMENT OF INACTIVATED POLIO VACCINE FROM ATTENUATED SABIN STRAINS FOR CLINICAL STUDIES AND TECHNOLOGY-TRANSFER PURPOSES, Yvonne E. Thomassen, Wilfried A.M. Bakker, Janny Westdijk, Aart G. Van ‘t Oever, Nico Van den Heuvel, Jan Hendriks, Gideon F.A. Kersten, and Leo A. Van der Pol (Article)

PDF

CLINICAL DEVELOPMENT OF FORMULATED THERAPEUTIC AND PROPHYLACTIC DNA-BASED VACCINES, Alain Rolland (Article)

PDF

AFTER THE LICENSE APPROVAL: HOW ANALYTICS CAN KEEP YOU IN THE MARKET, Robert Sitrin (Article)

PDF

CHALLENGES IN CONFRONTING PANDEMIC INFLUENZA USING NOVEL ADJUVANTED VACCINES, Louis F. Fries (Article)

PDF

BUILDING PROCESS UNDERSTANDING FOR VACCINE MANUFACTURING USING DATA MINING, Matthew Wiener (Article)

PDF

NIPAH/HENDRA: UNDERSTANDING THE LINKS BETWEEN HUMAN AND VETERINARY EMERGING DISEASES, Jules Minke (Article)

PDF

THE CHALLENGE OF DEVELOPING NEW GENERATION VACCINES FOR CONTROL AND ERADICATION OF FOOT AND MOUTH DISEASE IN SOUTH AMERICA, Susana Levy (Article)

PDF

PROCESS SCALE-UP AND OPTIMIZATION FOR PRODUCTION OF HIGH EFFICACY ORAL RABIES VACCINE, Amine Kamen, Chun Fang Shen, Stephane Lanthier, Danielle Jacob, Johnny Montes, and Andrew Beresford (Article)

PDF

CIM TECHNOLOGY: ENABELING ECONOMIC VACCINE PURIFICATION, Matjaz Peterka, Franci Smrekar, Tony Brazzale, Marko Banjac, Petra Kramberger, Milos Barut, Ales Podgornik, and Ales Strancar (Article)

PDF

SCALE-UP OF AN INTENSIFIED PROCESS FOR RAD35 ADENOVIRUS PRODUCTION USING THE PER.C6® CELL SUBSTRATE, Alfred Luitjens and Herman van Herk (Article)

PDF

NEW VACCINE TECHNOLOGIES: PROMISING ADVANCES MAY SAVE MORE LIVES, John Boslego (Article)

PDF

THE GLOBAL MANUFACTURE OF POLIO VACCINE IN THE ENDGAME OF ERADICATION, Philip Minor (Article)

PDF

VACCINE STABILIZATION – RESEARCH, COMMERCIALIZATION, AND IMPACT, Ray Cummings, Debra Kristensen, Dexiang Chen, and Michel Zaffran (Article)

PDF

INNOVATIVE THERAPEUTIC CANCER VACCINES IN CUBA: AN UPDATE, Luis Enrique Fernández (Article)

PDF

MANUFACTURING FLU VACCINE IN MEXICO: A MAJOR PUBLIC HEALTH AND TECHNOLOGY TRANSFER CHALLENGE, Roger Vinas (Article)

PDF

ESTABLISHING A PLATFORM FOR SPRAY DRYING INHALABLE VACCINES IN SOUTH AFRICA, Willem Germishuizen, L Venter, A Khosa, F Mudau, P.B. Fourie, B Pulliam, M Kabadi, A Schiermeier, and D.A . Edwards (Article)

PDF

RABIES VIRUS GLYCOPROTEIN (RVGP) EXPRESSION IN DROSOPHILA S2 CELLS AND BY SEMLIKI FOREST VIRUS (SFV). SYNTHESIS AND PROTECTION STUDIES, Carlos Pereira (Article)

PDF

PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-FREE SUSPENSION CULTURES OF HEK 293 CELLS, Érica A. Schulze (Article)

PDF

RNA BASED PLASMID SELECTION SYSTEM FOR ANTIBIOTIC-FREE PLASMID DNA VECTOR PRODUCTION, Aaron E. Carnes, Jeremy Luke, Justin Vincent, Clague Hodgson, and James Williams (Article)

PDF

ESCHERICHIA COLI PLASMID DNA FERMENTATION: STRAIN AND PROCESS-SPECIFIC EFFECTS ON VECTOR YIELD, QUALITY, AND TRANSGENE EXPRESSION, Aaron E. Carnes, Jeremy Luke, Justin Vincent, Clague Hodgson, and James Williams (Article)

PDF

PURIFICATION PROCESS DEVELOPMENT OF PROTEIN SUBUNIT BASED VACCINE CANDIDATES PRODUCED USING RECOMBINANT E. COLI EXPRESSION SYSTEM (Part - I), Davinder Chawla and Yan-Ping Yang (Article)

PDF

PURIFICATION PROCESS DEVELOPMENT OF PROTEIN SUBUNIT BASED VACCINE CANDIDATES PRODUCED USING RECOMBINANT E. COLI EXPRESSION SYSTEM (Part - II), Davinder Chawla and Yan-Ping Yang (Article)

PDF

DEVELOPMENT OF PROTEIN CAPSULAR MATRIX VACCINE (PCMV) TECHNOLOGY, Kevin P. Killeen, Ann Thanawastien, and Tom Griffin (Article)

PDF

A VACCINE PROTOTYPE USING BACULOVIRUS EXPRESSION SYSTEM FOR THE CONTROL OF AVIAN INFLUENZA VIRUS, Mauricio Realpe, R. Mora, L. Castellanos, F. Robles, and C. González-Hernández (Article)

PDF

POLY-METHYL VINYL ETHER-CO-MALEIC ANHYDRIDE NANOPARTICLES AS ANTIGEN DELIVERY AND ACTIVATING SYSTEMS, Carlos Gamazo, Ibai Tamayo, and Ana I. Camacho (Article)

PDF

DESIGN OF EXPERIMENT BASED JAPANESE ENCEPHALITIS VIRUS FORMALDEHYDE INACTIVATION OPTIMISATION FOR A VERO CELL DERIVED VACCINE, Michael Hughson (Article)

PDF

HUMAN CELLS FOR PROSTATE CANCER VACCINE THERAPY - THE IMPACT OF CENTRIFUGATION UPON KEY PRODUCT QUALITY ATTRIBUTES, Michael Delahaye, Katherine Lawrence, Carol Chu Mike Hoare, and Stephen Ward (Article)

PDF

ULTRA-SCALE DOWN STUDIES OF HUMAN CELL BIOPROCESSING FOR A PROSTATE CANCER VACCINE THERAPY - THE IMPACT OF CAPILLARY SHEAR, Juan Pablo Acosta Martinez, Katherine Lawrence, Carol Chu Mike Hoare, and Stephen Ward (Article)

PDF

APPLICATION OF ANIMAL-FREE RECOMBINANT BIOACTIVE PROTEIN SUPPLEMENTS TO IMPROVE THE PERFORMANCE OF CELL-BASED VIRAL VACCINE PRODUCTION, Kenneth Bertram, Marina Ross, Domenica Cavallaro, Larissa Chirkova, and Geoffrey Francis (Article)

PDF

DEVELOPMENT OF A MULTI-DOSE FORMULATION FOR PREVNAR 13™, Lakshmi Khandke, Cindy Yang, Jingrun Fan, Hanyoung Han, Ksenia Krylova Abbas Rashidbaigi, Bruce A. Green, and Kathrin U. Jansen (Article)